IL17A and cancer: Toll-like receptor (TLR) signaling pathway and transcriptional regulation in cancer were enriched in Ven and Ven-PegC treatment, while Janus kinases (JAK), signal transducer and activator of transcription proteins (STAT), mTOR and Interleukin 17 (IL17) were noted to be enriched upon PegC treatment.